Evidence map›Paper›PMID 21742314›Full record

ArticleCarbohydrate research2011

Ozonolysis of the double bond of the unsaturated uronate residue in low-molecular-weight heparin and K5 heparosan.

Sayaka Masuko, Kyohei Higashi, Zhenyu Wang, Ujjwal Bhaskar, Anne Marie Hickey, Fuming Zhang, Toshihiko Toida, Jonathan S Dordick, Robert J Linhardt

Abstract read
In one paragraph

Article in Carbohydrate research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Criegee Intermediates Beyond Ozonolysis: Synthetic and Mechanistic Insights.Angewandte Chemie (International ed. in English) · 2021
    Review
  2. Article
  3. Engineered heparins as new anticoagulant drugs.Bioengineering & translational medicine · 2017
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Sayaka MasukoDepartment of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Kyohei Higashi
Zhenyu Wang
Ujjwal Bhaskar
Anne Marie Hickey
Fuming Zhang
Toshihiko Toida
Jonathan S Dordick
Robert J Linhardt
Rensselaer Polytechnic Institute · USChiba University · JP

Funding

In vitro synthesis of recombinant heparan sulfateR01HL094463 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIU, JIAN, PAWLINSKI, RAFAL L · 2009 to 2021
$5.2M
Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined DrugsR01HL062244 · NHLBI · UNIVERSITY OF IOWA · PI DEANGELIS, PAUL L, LINHARDT, ROBERT J · 2001 to 2016
$4.1M
Development of a Bioengineered Heparin from a Non-Animal SourceR01HL096972 · NHLBI · RENSSELAER POLYTECHNIC INSTITUTE · PI DORDICK, JONATHAN S., LINHARDT, ROBERT J · 2009 to 2013
$3.9M
SEQUENCING THE POLYSACCHARIDE COMPONENT OF PROTEOGLYCANSR01GM038060 · NIGMS · UNIVERSITY OF IOWA · PI LINHARDT, ROBERT J · 1988 to 2012
$2.8M
An Artificial Golgi: Controlled GAG Synthesis and ScreeningR01GM090257 · NIGMS · RENSSELAER POLYTECHNIC INSTITUTE · PI DORDICK, JONATHAN S., LINHARDT, ROBERT J · 2009 to 2010
$597k
Heparin Glycan Microarray for ScreeningR41RR023764 · NCRR · SOLIDUS BIOSCIENCES, INC. · PI LINHARDT, ROBERT J · 2007 to 2008
$400k
NCRR NIH HHS R41 RR023764NHLBI NIH HHS HL094463NHLBI NIH HHS HL096972NHLBI NIH HHS R01 HL062244NHLBI NIH HHS R01 HL096972NIGMS NIH HHS GM090257NIGMS NIH HHS GM38060NIGMS NIH HHS R01 GM038060NIGMS NIH HHS R01 GM090257
6 · The paper itself

Abstract

Ozone is known to add across and cleave carbon-carbon double bonds. Ozonolysis is widely used for the preparation of pharmaceuticals, for bleaching substances and for killing microorganisms in air and water sources. Some polysaccharides and oligosaccharides, such as those prepared using chemical or enzymatic β-elimination, contain a site of unsaturation. We examined ozonolysis of low-molecular-weight heparins (LMWHs), enoxaparin and logiparin, and heparosan oligo- and polysaccharides for the removal of the nonreducing terminal unsaturated uronate residue. 1D (1)H NMR showed that these ozone-treated polysaccharides retained the same structure as the starting polysaccharide, except that the C4-C5 double bond in the nonreducing end unsaturated uronate had been removed. The anticoagulant activity of the resulting product from enoxaparin and logiparin was comparable to that of the starting material. These results demonstrate that ozonolysis is an important tool for the removal of unsaturated uronate residues from LMWHs and heparosan without modification of the core polysaccharide structure or diminution of anticoagulant activity. This reaction also has potential applications in the chemoenzymatic synthesis of bioengineered heparin from Escherichia coli-derived K5 heparosan.

Indexed as

DisaccharidesEnoxaparinHeparin, Low-Molecular-WeightMagnetic Resonance SpectroscopyMolecular StructureOzoneUronic AcidsDisaccharidesEnoxaparinHeparin, Low-Molecular-WeightheparosanLogiparinOzoneUronic Acids

Identifiers

PMID21742314
PMCPMC3229283
OpenAlexW2147525009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.